Phospho-PTK2B (Tyr579) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Generally, we can ship the products within 1-3 business days after receiving your orders. Delivery times may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery timeframes.
Synonyms
CADTK antibody; CAK-beta antibody; CAKB antibody; CAKbeta antibody; Calcium regulated non receptor proline rich tyrosine kinase antibody; Calcium-dependent tyrosine kinase antibody; Cell adhesion kinase beta antibody; E430023O05Rik antibody; EC 2.7.10.2 antibody; FADK 2 antibody; FADK2 antibody; FAK2 antibody; FAK2_HUMAN antibody; Focal adhesion kinase 2 antibody; MGC124628 antibody; PKB antibody; Proline-rich tyrosine kinase 2 antibody; Protein kinase B antibody; Protein Tyrosine Kinase 2 Beta antibody; Protein-tyrosine kinase 2-beta antibody; PTK antibody; PTK2B antibody; PTK2B protein tyrosine kinase 2 beta antibody; PYK2 antibody; RAFTK antibody; RAFTK2 antibody; Related adhesion focal tyrosine kinase antibody
Target Names
Uniprot No.

Target Background

Function
Proline-rich tyrosine kinase 2 beta (PTK2B), also known as Pyk2, is a non-receptor protein-tyrosine kinase that plays a crucial role in regulating the reorganization of the actin cytoskeleton. It is involved in various cellular processes, including cell polarization, migration, adhesion, spreading, and bone remodeling. Pyk2 is essential for proper humoral immune response and regulates the normal levels of marginal B-cells in the spleen and the migration of splenic B-cells. It is also required for normal macrophage polarization and migration to sites of inflammation. In T-cells, Pyk2 regulates cytoskeleton rearrangement and cell spreading, contributing to the regulation of T-cell responses. Furthermore, Pyk2 promotes osteoclastic bone resorption, a process that requires both PTK2B/PYK2 and SRC. It may also inhibit the differentiation and activity of osteoprogenitor cells. Pyk2 functions as a downstream signaling molecule for various receptors, including integrin, collagen, immune, G-protein coupled receptors (GPCR), cytokine, chemokine, and growth factor receptors. It also mediates responses to cellular stress. Upon activation, Pyk2 forms multisubunit signaling complexes with SRC and SRC family members, leading to the phosphorylation of additional tyrosine residues. These phosphorylated residues serve as binding sites for scaffold proteins, effectors, and substrates. Pyk2 regulates numerous signaling pathways, including activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascade, activation of NOS3, production of the cellular messenger cGMP, activation of the MAP kinase signaling cascade (MAPK1/ERK2, MAPK3/ERK1, and MAPK8/JNK1), and activation of Rho family GTPases (RHOA and RAC1). It also recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, regulating P53/TP53 activity, ubiquitination, and proteasomal degradation. Pyk2 acts as a scaffold protein, binding to both PDPK1 and SRC, facilitating SRC phosphorylation of PDPK1 at 'Tyr-9, 'Tyr-373', and 'Tyr-376'. It promotes the phosphorylation of NMDA receptors by SRC family members, contributing to the regulation of NMDA receptor ion channel activity and intracellular Ca(2+) levels. Pyk2 may also regulate potassium ion transport by phosphorylating potassium channel subunits. Furthermore, it phosphorylates SRC, increasing SRC kinase activity, and phosphorylates ASAP1, NPHP1, KCNA2, SHC1, ASAP2, RHOU, and PXN, with the latter requiring both SRC and PTK2/PYK2.
Gene References Into Functions
  1. LFA-1 cross-linking recruits and activates FAK1 and PYK2 to phosphorylate LAT selectively on a single Y-171 site that binds to the GRB2-SKAP1 complex and limits dwell times of T-cells with dendritic cells PMID: 28699640
  2. Pyk2 has a role in spine structure and synaptic function; its deficit contributes to Huntington's disease cognitive impairments PMID: 28555636
  3. Results provide evidence that Pyk2 phosphorylates STIM1 at its Y361 residue, activating thereby store-operated Ca(2+) entry. PMID: 28218251
  4. The authors' findings identify Pyk2 as a unique mediator of invadopodium formation and function and also provide a novel insight into the mechanisms by which Pyk2 mediates tumor cell invasion. PMID: 29133485
  5. Results show that VEGFA induces Pyk2 activation in mediating human retinal microvascular endothelial cell migration, sprouting and tube formation, and that Pyk2-mediated STAT3 activation is required for hypoxia-induced retinal neovascularization. PMID: 27210483
  6. Interestingly, rs2279590 locus has a widespread enhancer effect on two nearby genes, protein tyrosine kinase 2 beta (PTK2B) and epoxide hydrolase-2 (EPHX2); both of which have been previously associated with AD as risk factors. PMID: 28973302
  7. Multiple myeloma that is driven by deregulated iron homeostasis and/or Pyk2/beta-cateninn signaling is susceptible to deferasirox-induced apoptosis. PMID: 27602957
  8. In summary, our data suggested that PYK2 via S6K1 activation modulated AR function and growth properties in prostate cancer cells. Thus, PYK2 and S6K1 may potentially serve as therapeutic targets for PCa treatment. PMID: 27492635
  9. Our findings suggest that Pyk2 plays an important role in the coordination of stabilization of beta-catenin in the crosstalk between Wnt/beta-catenin and Wnt/Ca(2+) signaling pathways upon Wnt3a stimulation in differentiating hNPCs. PMID: 28694190
  10. STIM1-induced Ca(2+) signaling activates Pyk2 to inhibit the interaction of VE-PTP and VE-cadherin and hence increase endothelial permeability. PMID: 28385807
  11. Ascites and CCL18 stimulate the phosphorylation and expression of Pyk2, which positively regulates ascites-induced ovarian cancer cell migration. PMID: 27613122
  12. We demonstrated trophoblast cytoprotection by intervention with supraphysiological concentrations of relaxin, a process in part mediated through the PI3-kinase-Akt/PKB cell survival pathway. These results provide further rationale for clinical investigation of relaxin as a potential therapeutic in preeclampsia. PMID: 28122716
  13. PTK2B polymorphism (rs28834970) could modify the risk of late-onset Alzheimer's disease (LOAD), and PTK2B polymorphism (rs28834970) and APOE may interact to increase LOAD risk in a Han Chinese population. PMID: 27080426
  14. Studies suggest that PYK2 is a common downstream effector of ErbB and IL8 receptors, and that PYK2 integrates their signaling pathways through a positive feedback loop to potentiate breast cancer invasion. PMID: 26084289
  15. Pyk2 is a key downstream signaling molecules of CCR7 in SCCHN, which promotes SCCHN tumorigenesis and progression. PMID: 26352169
  16. Phosphoproteomic analysis identifies FAK2 as a potential therapeutic target for tamoxifen resistance in breast cancer. PMID: 26330541
  17. Pyk2-focal adhesion targeting domain interacts with and binds to leupaxin. PMID: 26866573
  18. Src has a role in priming Pyk2 (but not FAK) phosphorylation and subsequent activation downstream of integrins PMID: 26866924
  19. Data strongly suggest that chemokine-stimulated associations between Vav1, SLP-76, and ADAP facilitate Rac1 activation and alpha4beta1-mediated adhesion, whereas Pyk2 opposes this adhesion by limiting Rac1 activation. PMID: 26202465
  20. FAK and PYK2 functioned redundantly to promote the Wnt/beta-catenin pathway by phosphorylating GSK3beta(Y216) to reinforce pathway output-beta-catenin accumulation and intestinal tumorigenesis. PMID: 26274564
  21. This study identified Pyk2 as a cellular component required for the intracellular trafficking of HPV16 during infection. PMID: 26109718
  22. These results suggest that melatonin exerts anti-migratory and anti-invasive effects on glioma cells in response to hypoxia via reactive oxygen species-alphavbeta3 integrin-FAK/Pyk2 signaling pathways. PMID: 25889845
  23. data suggest a novel role for FAK in GPVI-dependent ROS formation and platelet activation and elucidate a proximal signaling role for FAK within the GPVI pathway. PMID: 25415317
  24. Orai1/Pyk2 pathway is essential for glioma migration and invasion. PMID: 25433371
  25. Pyk2-NDRG1 axis is possibly involved in conveying the anti-proliferative effect of beta-ionone in prostate cancer cells. PMID: 25219547
  26. Pyk2 has a role in integrin regulation of size and dynamics of signaling microclusters PMID: 25778396
  27. PYK2 is an intermediary component of Ca(2+) signaling between PKA-mediated and Tyr phosphorylations that is required for achieving functional human sperm capacitation. PMID: 25180269
  28. Data indicate that chicken paxillin leucine-aspartate LD2 and LD4 motifs preferentially dock at the helix 2/3 binding site of human Proline-rich tyrosine kinase 2 (Pyk2)-focal adhesion kinase (FAK). PMID: 25174335
  29. these data demonstrate that Pyk2 is a critical regulator of PI3K function downstream of the TCR. PMID: 25387834
  30. Data indicate the tumor-promoting role of proline-rich tyrosine kinase 2 (Pyk2) in multiple myeloma (MM), suggesting tyrosine kinase inhibitor as a therapeutic option in MM. PMID: 25217697
  31. inhibition of FAK, PYK2 and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines PMID: 24523919
  32. Pyk2 and Src are important in CCL18-induced breast cancer metastasis. PMID: 24142406
  33. High expression of proline-rich tyrosine kinase 2 is associated with hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway. PMID: 22618716
  34. Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation. PMID: 24097630
  35. Pyk2 is essential for skin wound reepithelialization in vivo and in vitro and that it regulates epidermal keratinocyte migration via a pathway that requires PKCdelta and MMP functions. PMID: 24598361
  36. Pyk2 is a shared key mediator of targeted-therapy induced adhesion and migration; Targeting Pyk2 may serve as an effective therapeutic strategy to reduce extramedullar relpase in acute promyelocytic leukemia and chronic myeloid leukemia. PMID: 24176282
  37. We hypothesize a potential direct or indirect role for SRC, RAF1, PTK2B genes in neurotransmission and in central nervous system signaling processes. PMID: 24108181
  38. Determine a crucial role of LRP1-mediated Pyk2 phosphorylation on hypoxia-induced MMP-9 activation and hVSMC migration and therefore in hypoxia-induced vascular remodeling. PMID: 24072693
  39. Both Pyk2 and phosphorylated Pyk2[pY881] are potential prognostic factors and therapeutic targets for non-small-cell lung cancer. PMID: 23922106
  40. Our results confirm that RTKs are frequently altered in chordomas. PMID: 23618355
  41. Results indicate that in vitro Pyk2 might function to regulate cell adhesion and motility following all-trans-retinoic acid (ATRA). PMID: 23587524
  42. We conclude that the effects of selenoprotein H on mitochondrial biogenesis and mitochondrial function are probably mediated through protein kinase A-CREB-PGC-1alpha and Akt/protein kinase B-CREB-PGC-1alpha pathways. PMID: 23220172
  43. Data indicate protein secretion pathways activated by monosodium urate (MSU) in macrophages, and reveal a novel role for cathepsin B and Src, Pyk2, PI3 kinases in the activation of unconventional protein secretion. PMID: 23292187
  44. These results identify a novel pathway of integrin alphaIIbbeta3 outside-in signaling and recognize the tyrosine kinase Pyk2 as a major regulator of platelet adhesion and spreading on fibrinogen. PMID: 23216754
  45. the non-catalytic functions of the kinases Fyn and Pyk2 were required for late stage human T cell adhesion. PMID: 23300847
  46. SOCS3 definitely plays roles in regulating Pyk2 signaling and cell motility in A549 cells. PMID: 23302305
  47. PAC1 regulates PYK-2 tyrosine phosphorylation in a calcium-dependent manner in lung cancer cell lines. PMID: 22581436
  48. findings showed that Pyk2 is overexpressed in squamous cell carcinoma of the head and neck; data suggest that CCR7 via Pyk2 and cofilin regulates the chemotaxis and migration ability of metastatic squamous cell carcinoma of the head and neck cells PMID: 22923218
  49. Down-regulation of both miR-517a and miR-517c contribute to hepatocellular carcinoma cells development through regulating Pyk2. PMID: 23142219
  50. Pyk2, which was strongly activated by IGF-I, was critical for IGF-IR-dependent motility. PMID: 22859931

Show More

Hide All

Database Links

HGNC: 9612

OMIM: 601212

KEGG: hsa:2185

STRING: 9606.ENSP00000332816

UniGene: Hs.491322

Involvement In Disease
Aberrant PTK2B/PYK2 expression may play a role in cancer cell proliferation, migration and invasion, in tumor formation and metastasis. Elevated PTK2B/PYK2 expression is seen in gliomas, hepatocellular carcinoma, lung cancer and breast cancer.
Protein Families
Protein kinase superfamily, Tyr protein kinase family, FAK subfamily
Subcellular Location
Cytoplasm. Cytoplasm, perinuclear region. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, focal adhesion. Cell projection, lamellipodium. Cytoplasm, cell cortex. Nucleus. Note=Interaction with NPHP1 induces the membrane-association of the kinase. Colocalizes with integrins at the cell periphery.
Tissue Specificity
Most abundant in the brain, with highest levels in amygdala and hippocampus. Low levels in kidney (at protein level). Also expressed in spleen and lymphocytes.

Q&A

What is PTK2B and what is the significance of Tyr579 phosphorylation?

Protein-tyrosine kinase 2-beta (PTK2B), also known as proline-rich tyrosine kinase 2 (PYK2) or focal adhesion kinase 2 (FAK2), is a non-receptor protein-tyrosine kinase that regulates reorganization of the actin cytoskeleton, cell polarization, cell migration, adhesion, spreading and bone remodeling . PTK2B plays critical roles in multiple signaling cascades, functioning downstream of various receptor types including integrin and collagen receptors, immune receptors, G-protein coupled receptors (GPCRs), and cytokine, chemokine and growth factor receptors .

Phosphorylation at Tyr579 is a key regulatory event in PTK2B function. The major activation sequence begins with phosphorylation at Tyr-402, which is the primary autophosphorylation site . This initial phosphorylation promotes interaction with SRC and SRC family members, which subsequently leads to phosphorylation at multiple sites including Tyr-579, Tyr-580, and Tyr-881 . Importantly, Tyr579 phosphorylation represents a critical step in the full activation of PTK2B and its downstream signaling capabilities.

How can I detect Phospho-PTK2B (Tyr579) in my experimental samples?

Detection of Phospho-PTK2B (Tyr579) can be accomplished through several methodological approaches:

  • Western Blot (WB): The most common method for detecting specific phosphorylation states. For optimal results with anti-Phospho-PTK2B (Tyr579) antibody, use dilutions between 1:500-1:2000 . A representative Western Blot analysis of 3T3 cells demonstrates detection of Phospho-PTK2B (Tyr579) at the expected molecular weight of 116kDa .

  • Immunohistochemistry (IHC): Effective for tissue sections with recommended dilutions of 1:100-1:300 .

  • Immunofluorescence (IF): Provides spatial information about protein localization with recommended dilutions of 1:50-200 .

  • Enzyme-Linked Immunosorbent Assay (ELISA): Useful for quantitative analysis with recommended dilutions of 1:20000 .

When designing experiments, it's essential to understand that Phospho-PTK2B (Tyr579) antibodies specifically detect PTK2B protein only when phosphorylated at Tyr579 . This phospho-specificity ensures that you are detecting the activated form of the protein.

What are the optimal storage and handling conditions for Phospho-PTK2B (Tyr579) antibodies?

To maintain antibody integrity and performance in experimental applications, follow these evidence-based guidelines:

  • Storage temperature: Store at -20°C for up to 1 year from the date of receipt .

  • Formulation stability: The antibody is typically provided in liquid PBS containing 50% Glycerol, 0.5% BSA, and 0.02% Sodium Azide, which helps maintain stability during storage .

  • Avoid freeze-thaw cycles: Repeated freezing and thawing significantly reduces antibody performance . Consider aliquoting the antibody upon receipt to minimize freeze-thaw cycles.

  • Centrifugation before use: Centrifuge the vial before opening to ensure complete recovery of contents, as recommended by manufacturers .

  • Working dilution preparation: When preparing working dilutions, use fresh, cold buffer and prepare only the amount needed for immediate use.

Proper handling significantly impacts experimental reproducibility and data quality when working with phospho-specific antibodies, which can be particularly sensitive to degradation.

What controls should I include when working with Phospho-PTK2B (Tyr579) antibody?

Implementing appropriate controls is crucial for validating antibody specificity and experimental results:

  • Positive controls: Cell lines or tissues known to express phosphorylated PTK2B at Tyr579. The 3T3 cell line has been validated for detection of Phospho-PTK2B (Tyr579) .

  • Negative controls:

    • Samples treated with phosphatase to remove phosphorylation

    • Cell lines with PTK2B knockdown or knockout

    • Samples from conditions where phosphorylation at Tyr579 is inhibited

  • Specificity controls:

    • Peptide competition assay using the immunizing peptide (derived from human PYK2 around the phosphorylation site of Tyr579 at amino acid range 545-594)

    • Comparison with total PTK2B antibody to assess phosphorylation state

  • Treatment controls: Samples with known modulators of PTK2B phosphorylation:

    • Calcium flux inducers (PTK2B is activated by calcium)

    • Angiotensin II, thapsigargin, or L-alpha-lysophosphatidic acid (LPA), which induce autophosphorylation and increase kinase activity

These controls help differentiate specific signals from background and confirm the phospho-specificity of the antibody detection system.

How can I optimize Western blot protocols specifically for Phospho-PTK2B (Tyr579) detection?

Optimizing Western blot protocols for phospho-specific detection requires careful attention to sample preparation and experimental conditions:

  • Sample preparation:

    • Harvest cells rapidly to preserve phosphorylation status

    • Include phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate, phosphatase inhibitor cocktails) in lysis buffers

    • Maintain samples at 4°C throughout processing

    • Use SDS-PAGE with adequate separation in the 110-120 kDa range to resolve the 116 kDa Phospho-PTK2B

  • Blocking optimization:

    • Use 5% BSA rather than milk, as milk contains phosphoproteins that can interfere with phospho-antibody detection

    • Consider commercial blocking buffers specifically formulated for phospho-protein detection

  • Antibody incubation:

    • Start with the recommended dilution range (1:500-1:2000)

    • Optimize incubation time and temperature (typically overnight at 4°C yields best results)

    • Use gentle agitation to ensure even antibody distribution

  • Signal enhancement techniques:

    • Consider signal amplification systems for low-abundance phospho-proteins

    • Optimize exposure times to capture signals within the linear range

  • Stripping and reprobing:

    • If comparing phospho-PTK2B to total PTK2B, consider running duplicate gels rather than stripping, which can reduce phospho-epitope detection efficiency

When analyzing Western blots, the expected molecular weight for Phospho-PTK2B (Tyr579) is 116 kDa, which matches both the observed and calculated molecular weight .

What are the mechanistic relationships between PTK2B Tyr579 phosphorylation and SRC family kinase signaling?

The interplay between PTK2B and SRC family kinases represents a sophisticated regulatory mechanism:

  • Activation sequence:

    • Initial PTK2B activation occurs in response to stimuli that elevate intracellular calcium concentration

    • Autophosphorylation at Tyr-402 creates a binding site for SRC and SRC family members via their SH2 domains

    • SRC binding leads to phosphorylation of additional sites including Tyr-579, Tyr-580, and Tyr-881

    • This multi-site phosphorylation fully activates PTK2B and creates additional binding sites for downstream effectors

  • Bidirectional regulation:

    • PTK2B phosphorylates SRC, increasing SRC kinase activity

    • SRC phosphorylates PTK2B at multiple sites, creating a positive feedback loop

    • The formation of a SRC-PTK2B complex is necessary for functions such as osteoclastic bone resorption

  • Differential signaling outcomes:

    • Phosphorylation at Tyr-579 and Tyr-580 enhances kinase activity

    • Phosphorylation at Tyr-881 specifically creates a binding site for GRB2, linking to the MAP kinase cascade

    • The PTK2B-SRC complex acts as a signaling hub, recruiting and activating numerous downstream effectors

  • Scaffold function:

    • PTK2B acts as a scaffold, binding both PDPK1 and SRC, thereby allowing SRC to phosphorylate PDPK1

    • This scaffolding function extends to promoting phosphorylation of NMDA receptors by SRC family members

Understanding this mechanistic relationship is crucial for experimental design, as manipulating one component will have effects on the entire signaling network.

How does Phospho-PTK2B (Tyr579) contribute to immune cell function and migration?

Phospho-PTK2B (Tyr579) plays critical roles in multiple immune cell types, affecting their activation, polarization, and migration:

  • B-cell regulation:

    • Required for normal levels of marginal B-cells in the spleen

    • Essential for normal migration of splenic B-cells

    • Contributes to humoral immune response regulation

  • T-cell signaling:

    • Regulates cytoskeleton rearrangement and cell spreading in T-cells

    • Contributes to the regulation of T-cell responses

    • Influences T-cell receptor signaling cascades

  • Macrophage function:

    • Required for normal macrophage polarization

    • Essential for macrophage migration towards sites of inflammation

    • In monocytes, adherence to substrata is required for tyrosine phosphorylation and kinase activation

  • Neutrophil activity:

    • Phosphorylation by MYLK promotes ITGB2 activation

    • Essential for triggering neutrophil transmigration during lung injury

  • Signaling mechanisms in immune cells:

    • Functions downstream of immune receptors, cytokine receptors, and chemokine receptors

    • Forms multisubunit signaling complexes with SRC and SRC family members

    • Activates multiple pathways including MAP kinase signaling cascade and Rho family GTPases

When designing experiments to study Phospho-PTK2B (Tyr579) in immune contexts, consider the cell-type specific roles and the relevant activation stimuli for each immune cell population.

What experimental approaches can reveal the temporal dynamics of PTK2B Tyr579 phosphorylation?

Studying the temporal dynamics of PTK2B phosphorylation requires methodologies capable of capturing rapid signaling events:

  • Time-course stimulation experiments:

    • Treat cells with known activators such as:

      • Calcium flux inducers

      • Angiotensin II

      • Thapsigargin

      • L-alpha-lysophosphatidic acid (LPA)

    • Harvest at multiple time points (e.g., 0, 1, 5, 15, 30, 60 minutes)

    • Analyze by Western blot with Phospho-PTK2B (Tyr579) antibody (1:500-1:2000 dilution)

  • Phosphorylation site-specific analysis:

    • Compare phosphorylation kinetics at multiple sites (Tyr-402, Tyr-579, Tyr-580, Tyr-881)

    • Determine the sequential order of phosphorylation events

    • Assess how disruption of one phosphorylation site affects the others

  • Live-cell imaging approaches:

    • Genetically encoded FRET-based biosensors for PTK2B phosphorylation

    • Phospho-specific intrabodies for real-time visualization

    • Correlative light and electron microscopy to link phosphorylation events with subcellular structures

  • Quantitative phosphoproteomics:

    • Mass spectrometry-based approaches to quantify multiple phosphorylation events simultaneously

    • SILAC or TMT labeling for comparative analysis across time points

    • Enrichment of phosphopeptides using titanium dioxide or immobilized metal affinity chromatography

These approaches can reveal not only the timing of Tyr579 phosphorylation but also its relationship to other phosphorylation events and its subcellular localization dynamics.

How can PTK2B Tyr579 phosphorylation be studied in the context of bone remodeling and osteoclast function?

PTK2B plays a crucial role in bone biology, particularly in osteoclast function, making it an important target for studies of bone homeostasis:

  • Osteoclast-specific experimental models:

    • Primary osteoclast cultures derived from bone marrow

    • RAW264.7 cell differentiation model

    • Transgenic mouse models with osteoclast-specific PTK2B modifications

  • Functional assays for osteoclast activity:

    • Bone resorption assays using dentin or hydroxyapatite substrates

    • Assessment of osteoclast formation, size, and multinucleation

    • Quantification of bone resorption markers in vitro and in vivo

  • Mechanistic investigation approaches:

    • Co-immunoprecipitation of PTK2B and SRC to assess complex formation

    • Phosphorylation site mutants (Y579F) to determine site-specific functions

    • Inhibition of specific kinases or phosphatases in the pathway

    • Assessment of actin cytoskeleton organization and attachment sites

  • Correlation with clinical parameters:

    • Relationship between PTK2B phosphorylation status and markers of bone turnover

    • Evaluation in models of pathological bone loss

Both PTK2B/PYK2 and SRC are necessary for osteoclastic bone resorption, with the Tyr-402 phosphorylated form serving as a docking site for SRC . This interaction is important for the organization of the osteoclast actin cytoskeleton and attachment sites, which are essential for bone resorption .

What are common challenges when detecting Phospho-PTK2B (Tyr579) in immunohistochemistry and immunofluorescence?

Researchers frequently encounter several challenges when visualizing Phospho-PTK2B (Tyr579) in tissue and cell specimens:

  • Fixation considerations:

    • Phospho-epitopes can be sensitive to overfixation with formaldehyde

    • Optimize fixation time (typically 10-15 minutes for cultured cells, 24 hours for tissues)

    • Consider alternative fixatives such as methanol or acetone for phospho-epitope preservation

  • Antigen retrieval optimization:

    • Heat-induced epitope retrieval in citrate buffer (pH 6.0) or EDTA buffer (pH 9.0)

    • Carefully optimize retrieval conditions (temperature, duration, buffer composition)

    • Test multiple retrieval methods to determine optimal phospho-epitope exposure

  • Background reduction strategies:

    • Extended blocking times (1-2 hours at room temperature)

    • Inclusion of 0.1-0.3% Triton X-100 for permeabilization

    • Use of specialized blocking reagents (e.g., Mouse on Mouse kit for mouse tissues)

    • Careful antibody titration (start with 1:100-1:300 for IHC, 1:50-200 for IF)

  • Signal amplification techniques:

    • Tyramide signal amplification for low-abundance phospho-proteins

    • Biotin-streptavidin amplification systems

    • Enhanced detection reagents for chromogenic or fluorescent visualization

  • Phospho-signal preservation:

    • Include phosphatase inhibitors in all buffers

    • Minimize time between specimen collection and fixation

    • Process all experimental groups simultaneously

The subcellular localization of Phospho-PTK2B (Tyr579) can vary depending on cell type and activation state, but may be found in the cytoplasm, perinuclear region, cell membrane, cell junctions, focal adhesions, cell projections, and nucleus .

How can I distinguish between different phosphorylation sites on PTK2B in my experiments?

Differentiating between closely related phosphorylation sites on PTK2B requires careful experimental design and validation:

  • Antibody validation approaches:

    • Peptide competition assays with phosphopeptides corresponding to different sites

    • Use of cells expressing phospho-site mutants (Y402F, Y579F, Y580F, Y881F)

    • Western blot comparison of multiple phospho-specific antibodies

    • Pretreatment with site-specific phosphatases

  • Sequential phosphorylation analysis:

    • Time-course studies to determine the order of phosphorylation

    • Inhibition of upstream kinases to block specific phosphorylation events

    • Correlation with functional outcomes specific to each phospho-site

  • Advanced analytical techniques:

    • Phospho-proteomics with mass spectrometry for site-specific quantification

    • Proximity ligation assays to detect specific phospho-sites in situ

    • Affinity purification followed by site-specific phospho-analysis

  • Functional discrimination:

    • Y402 phosphorylation is the major autophosphorylation site

    • Y579/Y580 phosphorylation occurs after SRC binding to phospho-Y402

    • Y881 phosphorylation creates a specific binding site for GRB2

Remember that Phospho-PYK2 (Y579) antibody specifically detects endogenous levels of PYK2 protein only when phosphorylated at Y579 . This specificity allows for discriminating between different activation states of the protein.

How is Phospho-PTK2B (Tyr579) implicated in neuronal function and neurological disorders?

PTK2B plays multifaceted roles in neuronal systems, with increasing evidence for its involvement in neurological conditions:

  • Neuronal signaling mechanisms:

    • Involved in calcium-induced regulation of ion channels

    • Contributes to activation of the MAP kinase signaling pathway in neurons

    • May phosphorylate voltage-gated potassium channel protein Kv1.2

    • Promotes phosphorylation of NMDA receptors by SRC family members

    • Regulates NMDA receptor ion channel activity and intracellular Ca²⁺ levels

  • Neurotransmitter system interactions:

    • May represent an important signaling intermediate between neuropeptide-activated receptors or neurotransmitters that increase calcium flux and downstream neuronal activity regulation

    • Involved in signaling downstream of G-protein coupled receptors commonly found in neurons

  • Stress response pathways:

    • Involved in osmotic stress-dependent alpha-synuclein 'Tyr-125' phosphorylation

    • Activation is highly correlated with c-Jun N-terminal kinase activity stimulation

    • Mediates responses to cellular stress generally

  • Experimental approaches for neuronal studies:

    • Primary neuronal cultures

    • Brain slice preparations

    • Conditional knockout models

    • Electrophysiological recording combined with phospho-specific antibody labeling

The relationship between PTK2B phosphorylation and neurological disorders is an emerging area of research, with potential implications for conditions associated with aberrant calcium signaling or cytoskeletal dysregulation.

What are the most promising techniques for quantitative analysis of Phospho-PTK2B (Tyr579) in complex biological samples?

Quantitative analysis of phosphorylation events in complex samples requires sophisticated methodological approaches:

  • Advanced mass spectrometry techniques:

    • Targeted MS approaches (SRM/MRM) for absolute quantification

    • Data-independent acquisition (DIA) for comprehensive phospho-profiling

    • Phospho-enrichment strategies (IMAC, TiO₂, phospho-specific antibodies)

    • Isobaric labeling (TMT, iTRAQ) for multiplexed quantification

  • High-throughput phospho-protein arrays:

    • Reverse-phase protein arrays with phospho-specific antibodies

    • Bead-based multiplex assays for simultaneous detection of multiple phospho-sites

    • Flow cytometry-based phospho-profiling

  • Single-cell phospho-analysis:

    • Imaging mass cytometry for spatial resolution of phospho-events

    • Single-cell Western blotting

    • Microfluidic platforms for single-cell phospho-proteomics

  • Computational analysis approaches:

    • Phospho-signal normalization to total protein

    • Network analysis of phosphorylation cascades

    • Integration of phospho-data with other -omics datasets

  • In vivo phosphorylation detection:

    • Genetically encoded biosensors

    • Intravital microscopy with phospho-specific probes

    • PET imaging with phospho-specific tracers

When conducting quantitative phospho-analysis, researchers should consider both the stoichiometry of phosphorylation (percentage of protein phosphorylated at a specific site) and the absolute abundance of the phosphorylated protein.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.